Cassiopea has just released excellent news regarding very positive interim Phase 2 results of Breezula. They now also call the product by its new chemical name of Clascoterone. Note that these are interim 6-month results and the trial is still ongoing. Update: Cassiopea stock almost doubled in the past week. This was due to their July 10 … Continue reading Cassiopea’s Breezula is the Real Deal→
In 2014, I wrote about a new yet to be released topical antiandrogen product called CB-03-01. Historically, antiandrogen products have usually been ingested orally and often led to adverse side effects. Early reports suggest that topical CB-03-01 has no significant side effects. In 2015, the Italian company (Cosmo Pharmaceuticals) that was compounding CB-03-01 changed the … Continue reading Update on Breezula (aka CB-03-01)→